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Different Functions of the GTPase Rho
in Prothymocytes and Late Pre-T Cells
Ricciarda Galandrini, Stefan W. Henning, kinases, together with ZAP-70 and interleukin-2 (IL-2)±
and Doreen A. Cantrell inducible T cell kinase, also mediate a/b TCR functions
Lymphocyte Activation Laboratory in the thymus (Molina et al., 1992; Levin et al., 1993;
Imperial Cancer Research Fund Laboratories Charlene-Liao and Littman, 1995; Negishi et al., 1995;
44 Lincoln's Inn Fields Groves et al., 1996; Van Oers et al., 1996). It has also
London WC2A 3PX been shown that pre-TCR and mature TCR signaling
United Kingdom involves the GTPasep21ras and theserine kinases Raf-1
and mitogen-activated protein kinase kinase (MEK)
(Swan et al., 1995; Alberola-Ila et al., 1996; Crompton
et al., 1996; O'Shea et al., 1996).Summary
Early thymocyte development in the DN compartment
is regulated by the cytokines stem cell factor (steel fac-Mice lacking thymic function of the GTPase Rho show
severe defects in fetal and adult thymopoiesis. Rho2 tor, SCF) and IL-7 (Moore and Zlotnik, 1995). Hence,
thymi are deficient in CD441CD251 pro-T cells and targeted disruptions in genes encoding CD117 (c-kit),
CD442CD251 early pre-T cells because Rho function IL-7, the IL-7 receptor (IL-7R) a chain, or the g subunit
is required for survival but not G1/S phase cell cycle of IL-7R have a major effect onearly thymocyte develop-
progression in these populations. The selective apop- ment and proliferative expansion (Peschon et al., 1994;
tosis defect in Rho2 prothymocytes can be rescued Cao et al., 1995; DiSanto et al., 1995; Rodewald et al.,
by expression of a bcl-2 transgene. A second function 1995; Von Freeden-Jeffry et al., 1995). However, the only
for Rho is seen in CD442CD252 late pre-T cells: Rho intracellular molecule implicated in early thymopoiesis
regulates cell cycle progression but not survival of to date is janus kinase 3 (Jak3), a tyrosine kinase that
this population. These studies show that the critical associates with the g subunit of IL-7R and is activated
processes of proliferation and survival are indepen- by IL-7 (Foxwell et al., 1995; Nosaka et al., 1995; Park
dently regulated during thymopoiesis and establish et al., 1995; Thomis et al., 1995). We recently reported
two different functions for Rho in the development of that theGTPase Rhohas a critical role in thymic develop-
early thymic progenitors. ment (Henning et al., 1997). Inactivation of Rho function
in the thymus was achieved by thymic targeting of a
Introduction transgene encoding C3 transferase from Clostridium
botulinum, which selectively ADP-ribosylates Rho within
T cell development within the thymus involves an or- its effector domain and thereby abolishes its biological
dered sequence of differentiation and proliferation. The function (Aktories and Just, 1995; Lang and Bertoglio,
coreceptors CD4/CD8 and the molecules CD44 and 1995). C3 transferase has been the main tool used to
CD25 provide key markers for the different stages of explore the function of Rho in a variety of cells, and its
thymopoiesis: CD4/CD8 double-negative (DN) cells specificity for the Rho GTPase has been extensively
make the transition to mature CD41 or CD81 single- verified (Hill et al., 1995; Lang and Bertoglio, 1995). Adult
positive (SP) cells via an intermediate CD41CD81 dou- transgenic mice that lack thymic Rho function show
ble-positive (DP) stage. Commitment to the T cell lineage maturational and proliferative defects during T cell de-
together with the initial waves of proliferative expansion velopment that severely impair the generation of normal
occur within the early thymic progenitor population, the numbers of thymocytes and mature peripheral T cells
CD4/CD8 DN thymocytes. This subset of cells can be
(Henning et al., 1997). The phenotype of the Rho2 thymi
further subdivided into four distinct phenotypic precur-
was very similar to the phenotype of thymi obtained
sor populations by analysis of their differential expres-
from mice lacking components of the IL-7R system. Thission of CD25 and CD44, providing a maturational se-
similarity indicates that Rho signals could be involvedquence of CD441CD252 (early lymphoid progenitor
in regulating the development of early thymic subsets.cells) → CD441CD251 (pro-T cells) → CD442CD251
In the present report we analyzed the role of Rho in(early pre-T cells) → CD442CD252 cells (late pre-T cells)
fetal thymocyte development, to determine more pre-(Godfrey and Zlotnik, 1993; Godfrey et al., 1993). The
cisely the function of Rho in thymopoiesis. In normaltransition of CD4/CD8 DN pre-T cells into CD4/CD8 DP
thymic development, CD4/CD8 DP cells can be detectedcells is regulated by the pre-T cell antigen receptor
at fetal day 16. In contrast, embryonic Rho2 thymi are(TCR) complex (Fehling et al., 1995). Mature a/b TCR
devoid of a/b-positive T cells or g/d cells and consistcomplexes control the processes of positive and nega-
entirely of CD4/CD8 DN cells throughout fetal life. CD4/tive selection and thus regulate a second crucial thymic
CD8 DP cells do not appear until after at least 1 weekcheckpoint, the differentiation of CD41CD81 DP to ma-
of postnatal life, and by 3±4 weeks of age Rho2 thymiture CD41 or CD81 SP thymocytes (von Boehmer, 1992).
contain the normal complement of thymic subsets, al-There has been some progress in the identification of
beit at severely reduced levels. Rho2 embryonic thymo-key signaling molecules that are central to the coordina-
cytes contain normal levels of the earliest thymic pro-tion of the complex processes of thymic development.
genitor cells (CD1171CD441CD252 cells) but fail toThe tyrosine kinases p56lck and p59fyn are involved in the
thymic checkpoints controlled by the pre-TCR. These accumulate subsequent developmental stages. In the
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Figure 2. Thymic Cellularity of C3 Transferase Transgenic Mice dur-
ing Embryonic and Early Postnatal Life
Thymi were isolated at the indicated ages of fetal and postnatal life
from C3 transferase transgenic (open boxes) and normal litter con-
trol (filled boxes) mice. Bars indicate the mean (n 5 10±14) of thymo-
cyte numbers.
thymi from fetuses at various gestational ages. We firstFigure 1. RT-PCR Analysis of Endogenous Rho A, Endogenous
p56lck, and the C3 Transgene in Fetal Thymocytes investigated the kinetics of expression of the C3 trans-
RNA was prepared from thymocytes of fetuses on the indicated gene during embryonic development in our transgenic
days. RNA was reverse transcribed, and the cDNA was amplified system. The transgene was found to be expressed in
for 35 cycles with specific primers as decribed in Experimental day 12 embryos (data not shown) and was present in
Procedures. After RT-PCR, theproducts weresubjected to Southern
day 13 thymic lobes, concomitant with the activity ofblot analysis.
the endogenous p56lck promoter (Figure 1). A compari-
son of thymocyte cellularity showed that the absolute
number of thymocytes was strikingly reduced in Rho2postnatal Rho2 thymus the normal CD4/CD8 thymocyte
subsets develop and these postnatal thymi contain all thymi relative to normal thymi. This loss of cellularity
was evident at day 14 of embryonic life and becameof the defined thymic subsets, although in markedly
reduced numbers. A defect in survival responses in the more dramatic as the main wave of proliferative expan-
sion started to occur at day 16. The severe reduction inpro-T cell (CD251) subset of DN thymocytes occurs in
both embryonic and adult mice. Also, a second problem thymic cellularity remained constant through peri- and
postnatal life (Figure 2).was detected in the most mature DN population, the
CD442CD252CD21 pre-T cells, in that loss of Rho func- The analysis of CD4 and CD8 expression on fetal thy-
mocytes revealed an impairment of maturation in Rho2tion resulted in a defect in cell cycle progression. The
present results thus show that the GTPase Rho has thymi (Figure 3). By fetal day 16, significant numbers of
ªtransitionalº cells expressing low levels of CD4 anda critical role in early thymopoiesis with two discrete
functions: Rho regulates survival signaling pathways in CD8 and more mature CD4/CD8 DP thymocytes were
detectable in normal mice. In day 18 normal embryonicCD251 prothymocytes and regulates cell cycle progres-
sion of the late CD252 DN thymocyte precursor popu- thymi, a large number of CD4/CD8 DP thymocytes could
be seen, and at birth they contained mature CD41 orlation.
CD81 SP thymocytes. In marked contrast, the data show
that Rho2 thymi were devoid of CD4/CD8 DP thymo-Results
cytes and completely lacked mature SP cells during
embryonic life (Figure 3). At birth, Rho2 thymi still com-Rho Inactivation Prevents the Generation of CD4/CD8
DP Cells during Embryonic Life prised immature CD4/CD8 DN thymocytes, with no CD4/
CD8 DP or mature CD4 and CD8 SP cells detectable.C. botulinum C3 transferase selectively ADP-ribosylates
the GTPase Rho, abolishing its biological function (Akto- Between days 4 and 10 after birth, CD4/CD8 DP thymo-
cytes and mature SP cells began to accumulate in C3ries, 1994). We exploited the selectivity of this toxin to
examine Rho function in thymocyte biology. To inhibit transgenic mice. In 2- to 3-week-old adult mice all thy-
mic subsets were present, and mature a/b TCR±positiveRho function in thymocytes, transgenic mice expressing
C3 transferase under the control of the p56lck proximal cells could be found, although cell numbers were greatly
reduced and very few T cellscould be found in peripheralpromoter were established (Henning et al., 1997). Loss
of Rho function caused a dramatic reduction in size and tissues such as spleen (Henning et al., 1997). The ab-
sence of CD4/CD8 DP cells in embryonic Rho2 thymicellularity of the adult thymus (Henning et al., 1997).
However, thymocyte differentiation did not appear to indicates that the development of the a/b TCR lineage
is blocked during embryogenesis. Analysis of the ex-be arrested, since all major thymocyte populations were
present in Rho2 thymi albeit, at greatly reduced levels. pression of a/b TCR complexes in cells from Rho2 em-
bryonic thymi confirmed that Rho inactivation inhibitsTo examine the role of Rho in embryonic thymic devel-
opment, we isolated C3 transgenic and normal littermate fetal development of a/b TCR1 cells (data not shown).
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Figure 3. The Development of CD4/CD8 Thymic Subsets in Embryonic Rho2 Thymi
Thymocytes from C3 transferase transgenic and normal litter control mice were isolated at the indicated ages of fetal and postnatal life,
stained for CD4 (PE) and CD8 (FITC), and analyzed by flow cytometry.
Rho Inactivation Impairs Generation Rho Inactivation Selectively Impairs the In
Vivo Survival of CD251 Thymocytesof a/b and g/d TCR Lineages
An alternative pathway of T cell development that leads The absence of DP or SP T cells in embryonic C3
transgenic thymi indicates that Rho function is requiredto the production of g/d TCR1 cells has been described
(Dudley et al., 1995). We assessed whether g/d cell de- to allow developmental transition of the CD4/CD8 DN
compartment, but it is not clear at which stage there isvelopment was compromised in C3 transgenic mice. In
fetal thymi, g/d T cells were detectable in day 17 em- a requirement for Rho function in DN ontogeny. Imma-
ture DN thymocytes have been subdivided into fourbryos, and CD4/CD8 DN embryonic thymocytes from
control mice contained approximately 10%±13% of g/d distinct phenotypic precursor populations by the differ-
ential expression of CD25 and CD44, providing a ma-TCR1 cells. By contrast, in Rho2 embryonic thymi, g/d
T cells were hardly detected (,1%) (Figure 4). Given turational sequence of CD441CD252 → CD441CD251
(pro-T cells) → CD442CD251 (early pre-T cells) →the overall reduction of thymic cellularity, these data
suggest a strict dependence for Rho in the generation CD442CD252 cells (late pre-T cells) (Godfrey and Zlot-
nik, 1993; Godfrey et al., 1993). An early developmentalof the g/d as well as the a/b lineage. Similar results were
obtained from the analysis of postnatal thymi. Analysis block in thymocyte ontogeny has been noted in mice
lacking expression of the pre-TCR complex or kinasesof cell numbers show that loss of Rho function results
in an impairment of the generation of both g/d and a/b activated by this complex, such as Src family kinases
p56 lck and p59fyn or the MEK (Crompton et al., 1996;TCR1 thymocytes (Figure 4).
Figure 4. g/d TCR Expression in Embryonic
Rho2 Thymi
Total thymocytes from day 17 C3 transferase
transgenic and normal litter control embryos
were stained for CD4, CD8, a panel of non±T
lineage±specific markers including NK1.1,
B220, Mac1, Gr1 (all biotinylated), and g/d
TCR(FITC) or a/b TCR (FITC). The percentage
of g/d TCR±positive cells on thymocytes lack-
ing expression of CD4, CD8, and non±T lin-
eage±specific markers is shown. The abso-
lute numbers were determined on the basis of
the percentages obtained by flow cytometry
and the total thymocyte numbers. g/d TCR:
control 5.4 6 1.6 3 104 (n 5 19); C3 transgenic
3.9 6 2.1 3 102 (n 5 9). a/b TCR: control 13 6
3.5 3 106 (n 5 11); C3 transgenic 2.8 6 1.5 3
105 (n 5 12).
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was normal in C3 transgenic mice. In contrast, the fre-
quency of CD251 cells was 30±70 times less than in
litter-matched controls, and CD442CD252 cells, which
constitute the immediate precursors of the DP cells,
were almost absent from C3 transgenic embryo thymi.
Although Rho2 thymocytes were blocked at the
CD1171CD441CD252 stage of development, there was
no accumulation of these early progenitor cells at this
point, raising the possibility that these cells make the
transition into the CD251 compartment but then fail to
proliferate or survive. We considered this a possibility
because the acquisition of CD25 antigen by CD441
CD252 cells is an event that is accompanied by exten-
sive proliferation. The loss of CD251 cells could thus be
explained by a failure of the proliferative expansion of
the CD251 population in Rho2 thymi. The rate of prolifer-
ative expansion (cellular mass) of any given population
of cells is determined by a balance of the rate of cellular
division and the rate of cell survival and apoptosis. Our
previous studies have shown increased levels of apop-
totic cells in DN thymocytes from adult C3 transgenic
thymi (Henning et al., 1997).
In the present experiments we examined whether thisFigure 5. Flow Cytometric Analysis of CD44 and CD25 Expression
in Embryonic Rho2 Thymi reflected a general increase in apoptosis in the different
subsets of DN cells or whether it was restricted to a(A) Thymocytes isolated from C3 transferase transgenic and normal
litter control day 16 embryos were stained for CD44 (PE), CD25 particular subpopulation of precursor cell. The fluores-
(FITC), and CD117 (biotinylated). Shown are representative dot blots cent dye 7-amino-actinomycin D (7-AAD) was used to
of C3 transgenic and normal litter control mice; the percentages of detect apoptotic cells on the basis of their increased
populations falling into individual quadrants are indicated.
cell membrane permeability (Schmid et al., 1994). Using(B) The absolute number of thymocytes belonging to CD1171
7-AAD in combination with the CD44 and CD25 markersCD441CD252 populations and CD441CD251, CD442CD251, and
we were able to quantitate the levels of apoptotic cellsCD442CD252 cells was calculated on the basis of percentages ob-
tained. Data are the means 6 SD of cell numbers recovered from detected in the single CD44/CD25 subpopulations. The
the whole thymus (control n 5 9; C3 transgenic n 5 5). In C3 data in Figure 6 show 7-AAD analysis of day 16 embry-
transgenic (Tg) mice, the cells falling into the CD442CD252 subset onic thymocytes and reveal no differences in the fre-
contain a very small percentage of CD21 cells (see Figure 8A), which
quency of apoptotic cells within the early thymocytemark the pre-T cell population. NLC, Normal litter control.
precursor (CD441CD252). However, we observed a
marked increase in levels of apoptosis in CD251 cells
Groves et al., 1996; Van Oers et al., 1996). In these mice, isolated from Rho2 thymi compared to those of control
cells accumulate at the CD442CD251 early pre-T cell littermates. This was found in both the CD251CD441
stage. There is also an earlier developmental checkpoint and CD251CD442 compartments throughout embryonic
revealed in mice lacking expression of the IL-7R a chain, and adult life (data not shown). There were no differ-
in which there is a lack of CD441CD251 pro-T cells ences in the levels of apoptosis in embryonic CD442
(Peschon et al., 1994). To establish the point of develop- CD252 thymocytes obtained from Rho2 and normal
mental arrest in Rho2 thymi, we performed detailed phe- thymi (data not shown). The apoptosis characterization
notypic analysis of early thymic precursor cells. of CD442CD252 pre-T cells in the adult are described
Figure 5A shows the typicaldistribution of the different in a later section of this report.
DN thymocyte subpopulations in a day 16 embryonic Cell cycle progression and survival of the CD251 com-
thymus. Four distinct subsets could be identified in nor- partment is strictly dependent on stromal-derived cyto-
mal mice: CD441CD252, CD441CD251, CD442CD251, kines. Notably, IL-7R and c-Kit have been shown to be
and CD442CD252. In comparison, Rho2 thymi were se- key signaling molecules regulating survival and prolifer-
verely deficient in CD251 subsets and consisted mainly ation within this thymocyte subset (Moore and Zlotnik,
of CD441CD252 cells that contain the early progenitor 1995; Rodewald et al., 1997). Embryonic thymocytes
subset that migrates from fetal liver into the thymus. from normal mice can be maintained in in vitro cultures
Thus, in Rho2 thymi, T cell development is arrested prior in the presence of IL-7 and SCF (Moore and Zlotnik,
to the prothymocyte cell stage, and there are very few 1995). We found that Rho2 thymocytes could not survive
cells of the subsequent CD441CD251 stages. On the in vitro in the presence of these cytokines (data not
basis of fluorescence-activated cell sorter analysis data shown). We asked whether the survival defect observed
using CD44, CD25, and CD117 (c-Kit) and total thymo- in Rho2 thymocytes both in vivo and in vitro might be
cyte numbers, we calculated the absolute number of due to a deficit in the expression of cytokine receptors.
cells belonging to the various CD44/CD25 subsets (Fig- Using three-color immunofluorescence analysis we
ure 5B). These data show that Rho was not required were able to analyze IL-7R and c-Kit expression in the
to generate a normal population of the earliest thymic different DN subpopulations. The data in Figure 7A show
that the expression of these cytokine receptors in theprogenitors (CD1171CD441CD252); in fact, their number
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Figure 6. Ex Vivo Apoptosis of CD44/CD25
Subpopulations of Rho2 Embryonic Thymi
(A) Thymocytes isolated from day 16 embry-
onic C3 transferase transgenic and normal
litter control mice were stained for CD44 (PE),
CD25 (FITC), and the fluorescent dye 7-AAD.
Three to five different C3 transferase trans-
genic thymi were pooled to generate approxi-
mately 1.5 3 105 cells per sample and thus
allow quantitative analysis. Shown is 7-AAD
staining of the indicated thymic subpopula-
tions; the percentage of cells within the
marker is indicated.
(B) Mean results of three independent experi-
ments carried out as in (A).
CD251 compartment from Rho2 thymi was comparable a large number of the C3 transgenic mice, and it is clear
from the analysis of the DN thymic compartment withto that of normal littermate controls.
There are a series of checkpoints in the life cycle of CD44/CD25 markers that these cells accumulate only
between days 4 and 10 of postnatal life. Down-regula-mammalian cells, and cells that fail to traverse these
are programmed to die by apoptosis. It has been pro- tion of CD25 is associated with the acquisition of the
CD2 molecule (Lalli et al., 1996; Rodewald et al., 1993).posed that Rho function regulates G1/S-phase transi-
tion and cytokinesis in fibroblasts (Olson et al., 1995; The CD21 cells within the CD442CD252 compartment
constitute the rapidly dividing population that furtherDutartre et al., 1996). We considered the possibility that
the increased apoptosis in the CD251 Rho2 thymocytes differentiates into DP thymocytes. In day 16 normal em-
bryos, CD21 cells comprised 70% of the CD4/CD8 DNoccurred as a result of cell cycle arrest. To investigate
this possibility we examined the cell cycle status of day thymocytes. In contrast, CD21 thymocytes were present
at severely depleted levels in day 16 C3 transgenic em-16 Rho2 embryonic thymocytes compared to littermate
controls. The data in Figure 7B show the cellular DNA bryos (Figure 8A, left). The loss of CD21 cells was consis-
tent with the observed absence of DP thymocytes. Ap-content of the CD251 subsets analyzed by three-color
flow cytometric analysis combining DNA and cell sur- preciable numbers of CD21 thymocytes were first
detected a few days after the birth in Rho2 mice, coinci-face staining. No salient differences between the cell
cycle profile displayed by Rho2 and normal CD251 cells dentally with the appearance of DP thymocytes (Figure
8A, right).could be seen. Notably, Rho2 CD251 cells were not
arrested in either the G0/G1 or the G2 phases of the We had observed a major survival defect in Rho2
CD251 DN cells (Figure 6), and we assessed whethercell cycle. These results indicate that Rho function is
required for cell survival but not cell cycle progression there was an impairment of the survival responses in
the late CD442/CD252/CD21 cells. The data in Figureof the CD251 DN thymocyte populations.
8B (top) show that levels of cell viability in CD442/
CD252/CD21 thymocytes isolated from normal andRho Regulates Cell Cycle Progression but Not
Survival Responses of CD442CD252CD21 Rho2 thymi were comparable, in contrast to the greatly
increased levels of cell death noted in the Rho2 CD251Late Pre-T Cells
The most mature DN thymic subpopulation are the thymic compartment. However, fluorescence-activated
cell sorter analysis of the cellular DNA content of theCD442CD252 cells. As described in Figure 5, we failed
to detect significant numbers of these CD442CD252 CD21 DN thymocytes showed that Rho2 cells contained
a higher percentage of cells in the G1 phase of the cellcells in embryonic Rho2 thymi. We have now analyzed
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(Oosterwegel et al., 1997). Interestingly, the failure of
IL-7R a chain±deficient thymocytes to make the DN-
to-DP transition can be reversed by expression of the
HY-TCR transgene (Crompton et al., 1997). Expression
of a TCR transgene also reverses the DN block in
RAG-deficient mice that fail to express the pre-TCR
complex (Shinkai et al., 1993).
We asked whether the introduction of an already re-
arranged TCR was sufficient to overcome the develop-
mental block and the defect in cellularity observed in
Rho2 thymi. C3 transgenic mice were crossed onto HY-
TCR transgenic mice. The HY-TCR recognizes a male
antigen±derived peptide presented in the context of the
major histocompatibility complex class I molecule
H-2Db, leading to massive deletion of DP thymocytes in
male mice (Kisielow et al., 1988); therefore H-2Db±
positive female mice were analyzed. The HY mice were
analyzed 1 day after birth for the frequency of CD4/CD8
thymic subsets, and control HY mice showed the typical
profile of a normal mouse with a substantial proportion
of thymocytes (70%±80%) belonging to the CD4/CD8
DP subset. In contrast, single C3 transgenic thymi
lacked any CD4/CD8 DP thymocytes, and the presence
of the HY-TCR transgene did not reconstitute this devel-
opmental block. HY/C3 thymi were still blocked at the
DN stage, as observed for the single C3 transgenic mice
(Figure 9). Moreover, thymocyte numbers in double
transgenic mice remained at the levels observed in C3
transgenic mice, approximately 10-fold less than those
in HY-TCR female or normal control age-matched mice
(Figure 9). This demonstrated that the presence of the
HY-TCR transgene does not reconstitute the normal thy-
mocyte subsets and cellularity in C3 transgenic mice.
Expression of a bcl-2 Transgene Partially
Rescues the Defects in Rho2 Thymi
One defect in the Rho2 thymi is the survival defect in
Figure 7. Cytokine Receptor Expression and Ex Vivo Cell Cycle Sta- the CD251 prothymocyte population. Extensive studies
tus of Rho2 Thymi
have shown that overexpression of the protooncogene
(A) Thymocytes isolated from day 16 embryonic C3 transferase
bcl-2 protects thymocytes against physiological in-transgenic and normal litter control mice were stained for CD25
duced apoptosis (Strasser et al., 1995). Em-bcl-2-25(biotinylated) and IL-7R (revealed by a secondary FITC MAb) or c-Kit
mice express the bcl-2 protooncogene at early stages(CD117) (FITC). CD251 cells were gated and examined for IL-7R or
c-Kit expression. Representative histograms of C3 transgenic (solid in thymopoiesis (Strasser et al., 1991). We therefore
line) or normal litter control (shaded) are shown. crossed the C3 transgenic mice onto Em-bcl-2-25 mice
(B) Flow cytometric analysis of cellular DNA content of day 16 embry- to investigate whether the introduction of a survival sig-
onic thymocytes counterstained for CD44 (PE) and CD25 (FITC).
naling molecule could rescue the developmental defectFlow cytometric analysis was performed on 2 3 105 events acquired
in Rho2 thymi.for each sample. Percentage of Hoechst 33342±positive cells was
A readily discernible defect in the Rho2 thymi is thecalculated within the indicated subsets on the basis of CD44 and
CD25 expression. The results of three independent experiments are loss of the CD251 DN prothymocyte population. As
shown. shown in Figure 10, the presence of bcl-2 rescued this
phenotype and reconstituted the CD251 DN subset.
Moreover, bcl-2/C3 transferase transgenic mice con-cycle and significantly fewer (50%) cycling cells (Figure
8B, bottom, and Figure 8C). The CD442CD252CD21 tained 4- to 5-fold higher numbers of thymocytes when
compared with littermates carrying only the C3 trans-cells are the compartment in which major thymic expan-
sion occurs, and cell cycle defects in this compartment ferase transgene (Table I). However, the introduction of
the bcl-2 transgene does not completely restore thymicwould contribute to the low cellularity in Rho2 thymi.
cellularity to normal levels. In addition, expression of
thebcl-2 transgene does not accelerate the rate atwhichA Transgenic TCR Cannot Rescue the Maturation
Defect Observed in Rho2 Mice the Rho2 thymocytes make the CD4/CD8 DN-to-DP
transition. In C3/Em-bcl-2-25 mice, no DP thymocytesFetal Rho2 thymi show a developmental arrest in the
CD4/CD8 DN compartment that is very similar in pheno- could be detected during embryonic life, and as in the
single C3 transgenic mice, CD4/CD8 DP thymocytestype to IL-7R a chain±deficient mice. IL-7 has been impli-
cated in the regulation of TCR gene rearrangements and mature a/b T cells emerged only postnatally (data
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Figure 9. Thymic Cellular Composition of Rho2/HY-TCR Transgenic
Female Mice
Flow cytometric analysis of CD4 and CD8 expression in HY-TCR/
C3 transferase transgenic mice and HY-TCR transgenic litter mate
controls. Thymocytes from 1 day old female mice were stained for
CD4 (PE) and CD8 (FITC). Representative dot blot histograms are
shown. The absolute number of cells recovered from the whole
thymus was: wild type 3.1 6 0.9 3 106 (n 5 9), HY-TCR 3.2 6 1.2
3 106 (n 5 7), C3 transferase 4 6 0.3 3 105 (n 5 5), HY-TCR/C3
transferase 2.4 6 0.4 3 105 (n 5 6).
not shown). Thus, expression of bcl-2 compensates for
the effect of Rho inactivation in the CD251 population
of prothymocytes, resulting in a partial rescue of thymic
hypocellularity in C3 transgenic mice. However, expres-
sion of bcl-2 does not rescue the DN-to-DP transition
block that occurs in Rho2 thymic development.
Discussion
In the present study we have determined the role of the
GTPase Rho in embryonic and postnatal thymic devel-
opment. Embryonic and adult thymi lacking Rho func-
tion show a massive loss in cellularity with impairment of
the generation of both a/b and g/d TCR cells. In marked
contrast to normal thymocyte development, embryonic
Rho2 thymi are effectively devoid of a/b and g/d TCR
cells and consist entirely of CD441CD252CD42CD82
early thymic progenitor cells throughout fetal life. CD4/
CD8 DP cells do not appear until after at least 1 week
of postnatal life, and by 3±4 weeks of age Rho2 thymi
contain the normal complement of thymic subsets, al-
beit at severely reduced levels. Our studies also reveal
two different functions for Rho in thymocyte develop-
ment. First, Rho is required for survival responses inFigure 8. Frequency, Ex Vivo Cell Cycle, and Apoptosis of Rho2
embryonic and adult CD441CD251 pro-T cells andLate Pro±T Cells
CD442CD251 early pre-T cells but not for G1/S phase(A) Flow cytometric analysis of CD2 expression on thymocytes iso-
lated from day 16 embryos and 1-week-old C3 transferase cell cycle progression of these populations. The CD251
transgenic and normal litter control mice. Total thymocytes were compartment contains a/b and g/d TCR precursors, and
stained for CD4, CD8, a panel of non±T lineage±specific markers the striking reduction of this thymocyte population ex-
including NK1.1, B220, Mac1, Gr1 (all biotinylated), and CD2 (FITC).
plains why there is a depletion of both T cell lineagesCD4, CD8, and non±T lineage±negative cells were gated and ana-
in Rho2 thymi. Second, Rho function is required forlyzed for expression of CD2. The percentage of cells within the
cell cycle progression of CD442CD252 late pre-T cells,marker is indicated.
(B) (Top) Flow cytometric analysis of ex vivo apoptosis. Total thymo- although Rho isnot required for the survival of this popu-
cytes from 1-week-old C3 transferase transgenic and normal litter lation of cells. These results identify a novel biological
control mice were stained for CD4, CD8, a panel of non±T lineage± role for the GTPase Rho as a critical signal in early
specific markers including NK1.1, B220, Mac1, Gr1 (all FITC), CD2
thymopoiesis. The data also showthat thereare different(PE), and the fluorescent dye 7-AAD. Representative histograms of
7-AAD staining within the gated CD2-positive and CD4, CD8, and
non±T lineage±negative thymocytes are shown. Analysis was per-
formed on7 3 105 cells. (Bottom) Flow cytometric analysis of cellular
DNA content. Total thymocytes from 1-week-old C3 transferase gated CD2-positive and CD4, CD8, and non±T lineage±negative thy-
transgenic and normal litter control mice were stained for surface mocytes are shown. Analysis was performed on 7 3 105 cells.
markers as in (A). Cellular DNAwas then stained with Hoechst 33342. (C) Mean of Hoechst 33342±positive cells gated as in (B), bottom,
Representative histograms of Hoechst 33342 staining within the representing three separate experiments.
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Table 1. Thymic Cellularity of 4-Week-Old Mice
bcl-2/C3
bcl-2 C3 Double-
Wild-Typea Transgenic Transgenic Transgenic
280 6 93 3 106 343 6 100 3 106 8 6 3 3 106 38.7 6 15 3 106
n 5 9 n 5 14 n 5 4 n 5 10
Data are means 6 SD.
a Nontransgenic normal litter control.
CD442CD252CD21 late pre-T cells. Survival and prolifer-
ation in the CD251 thymocyte compartment is regulated
by IL-7, whereas thymic progenitors and late pre-T cells
are dependent on c-Kit and the pre-TCR complex, re-
spectively, for the initiation of survival responses. Inter-
estingly, IL-7Ra±deficient mice show a skewed distribu-
tion of normal thymocyte subsets with an increased
percentageof CD4/CD8 DN cells and a lossof CD251 DN
thymocytes (Peschon et al., 1994). The present results
indicate that IL-7R and Rho are regulating responses in
the same thymocyte subpopulation (CD251 DN cells)
Figure 10. Flow Cytometric Analysis of CD44 and CD25 Expression and implicate Rho in the survival responses regulated
in Rho2/ Em-bcl-2 Thymi and Their Em-bcl-2 or Rho2 Littermate by the IL-7R complex. However, c-Kit/SCF is a second
Controls
receptor±ligand pair that drives the expansion of very
Total thymocytes from 4-week-old non-transgenic (wild-type), Em- immature thymocytes in vivo. IL-7 and c-Kit/SCF havebcl-2 transgenic, C3 transferase transgenic and Em-bcl-2/C3 trans-
some partially overlapping functions in the regulation offerase double transgenic mice were stained for CD44 (PE), CD25
early thymocyte growth (Rodewald et al., 1997), and the(FITC) and CD4, CD8, a panel of non±T lineage±specific markers
requirement for Rho function in thymocyte developmentincluding B220, NK1.1, Mac1, Gr1 (all biotinylated). Representative
dot blots of CD4, CD8 and non±T lineage±negative thymocytes are may also reflect involvement of Rho in c-Kit/SCF signal-
shown. ing. Whether there is a direct coupling of the c-Kit or
the IL-7R to Rho remains to be determined, but it is
known that these receptors recruit and activate phos-signaling requirements for the regulation of survival and
phatidylinositol 3-kinase, which is an established up-cell cycle progression in pro-T cell and late pre-T cells.
stream regulator of the GTPase Rho in fibroblasts (Ven-The increased levels of apoptosis within the CD251
kitaraman and Cowling, 1994; Reif et al., 1996).Whateversubsets results in almost the complete deletion of
the details of Rho regulation in thymocytes, the abilityCD251 cells from both embryonic and adult thymi. This
of Rho to regulate cell cycle progression and survivalsurvival defect can be rescued by expression of a bcl-2
differentially in different thymic subsets indicates thattransgene resulting in a restoration of CD251 cells in
these procceses are not coordinately regulated duringRho2 thymi and a clear rescue of thymic cellularity. Rho2
thymopoiesis. Our data thus exclude the possibility thatthymi contain 5%±10% of normal levels of thymocytes;
the apoptosis in CD251 cells caused by Rho inactivationexpression of bcl-2 restores this to 30%±40% of normal
results from a failure of cells to enter the cell cycle,levels. This striking result indicates that the survival de-
because normal levels of cycling cells could be seen infect plays a major role in the loss of thymocyte cellularity
the CD251 Rho2 thymi.seen in Rho2 thymi. The failure of bcl-2 expression to
T cell development requires interactions between thy-rescue fully the phenotype of the Rho2 thymi might have
mocytes and stromal cells, and it is the stromal cells
two explanations: first, the cell cycle progression defect
that are the source of the cytokines that regulate survival
in the CD442CD252CD21 late pre-T cells may also con-
responses (Anderson et al., 1996). We have not yet
tribute to the observed hypocellularity in Rho2 thymi. looked at the role of Rho in mediating thymocyte±
Alternatively, it has been shown recently that expression stromal cell interactions, but it is noteworthy that Rho2
of bcl-2 can itself suppress T cell cycle progression thymocytes could not survive in vitro in the presence of
(O'Reilly et al., 1996), raising the possibility that although exogenous IL-7 and a cocktail of survival factors (data
expression of bcl-2 rescues the survival defect in Rho2 not shown), indicating that the loss of Rho function di-
thymi, it may exacerbate the cell cycle progression de- rectly impairs the cytokine-mediated intracellular sur-
fect in the pre-T cell population and introduce cell cycle vival responses. At the moment, the link between
progression defects in other Rho2 thymic subsets. Rho2mediated signaling and survival or apoptosis is
Previous studies have shown a link between C3-medi- unknown. One mechanism for the modulation of survival
ated inactivation of Rho and the induction of apoptosis responses is induction of the expression of the proteins
in a murine thymoma cell line EL4 (Moorman et al., 1996). Bcl-2 and Bcl-x (Linette et al., 1994; Boise et al., 1995).
Our data show that the role of Rho as a critical regulator It is also becoming clear that kinase pathways regulated
of survival in T cells is restricted to selected subpopula- by cytokines may be able to regulate the formation of
tions. Rho function is thus required to suppress apop- complexes between Bcl-2/Bcl-x and dimerization part-
totic responses within the CD251 subset of DN thymo- ners, such as BAD, that antagonize the survival re-
sponses of these proteins (Zha et al., 1996). In thiscytes but not in CD441CD252 thymic progenitors and
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context, it is unclear how cytokines control survival re- defect of thymocyte development postnatally that re-
sults in a depletion of the peripheral compartment (Ver-sponses in prothymocytes.
Upon successful TCR b chain rearrangement, signals beek et al., 1995). The present data show a differential
requirement for Rho function in fetal and adult thymo-generated from a pre-TCR complex allow the second
major phase of thymocyte expansion and the transition poiesis, indicating that the signaling pathways govern-
ing different thymic checkpoints differ in adult and em-from the early pre-T cell stage to the late pre-T cell
and DP stages. Thus, survival, differentiation, and the bryonic life. Embryonic thymi lacking Rho function are
effectively devoid of all but the earliest thymic progenitorproliferative expansion of the late DN pre±T cell popula-
tion is initiated by pre-TCR signals (Hoffman et al., 1996). population of cells. In postnatal life, however, mature T
cells develop but at greatly reduced levels. This indi-We observed a cell cycle progression defect in the late
DN pre-T cell population isolated from Rho2 thymi. The cates a partial redundancy for Rho function in thymocyte
development in the adult. It should be emphasized, how-defects in cell cycle progression of these cells were not
accompanied by increased levels of apoptosis within ever, that the proliferative expansion defects caused by
loss of Rho function are maintained in both adult andthis population. This indicates a role for Rho in the prolif-
erative but not the survival signals initiated by the pre- embryonic life. Dissecting how Rho exerts its effects
upon different early thymocyte subpopulations and dif-TCR. The failure of proliferative expansion in Rho2 pre-T
cells indicates some signaling defect that probably ex- ferentially controls cell survival and cell cycle progres-
sion will be a challenge. Nevertheless, the present re-plains the delay in the DN-to-DP transition seen in the
Rho2 thymi. Mice with severe combined immunodefi- sults show that Rho signals will be the key to the
complex regulatory networks that control early thymo-ciency and RAG-1± or RAG-2±deficient mice show a
nearly complete block in thymocyte differentiation at poiesis.
the DN stage. This block can beovercome by expression
of a TCR transgene, indicating that expression of the
Experimental ProceduresTCR complex is rate limiting for the DN-to-DP transition
(Shinkai et al., 1992; Rothemberg et al., 1993). The DN- Mice
to-DP transitional block observed in Rho2 mice was not Mice were bred and maintained under specific pathogen-free condi-
rescued by the expression of a transgenic TCR, which tions in the Imperial Cancer Research Fund Biological Resources
Unit. Transgenic mice expressing the C. botulinum C3 transferaseindicates that expression of TCR complexes is not rate
gene in the thymus under the control of the proximal p56lck promoterlimiting in Rho2 thymi. Nevertheless, cell cycle progres-
were generated as previously described (Henning et al., 1997). Thission defects in late pre-T cells indicate that Rho function
promoter directs transgene expression in the thymus and has been
is required ªdownstreamª of the pre-TCR complex. A used extensively to target transgene expression in the thymocyte
number of other signaling molecules have been impli- compartment (Chaffin et al., 1990; Abraham et al., 1991; Anderson
cated in pre-TCR signaling in the late pre-T cell popula- et al., 1992; Alberola-Ila et al., 1995). C3 embryos were obtained by
mating C57BL/6 females with C3 transferase transgenic adult males.tion: the tyrosine kinases p56 lck and p59fyn, the tyrosine
Embryo thymi were obtained from time-mated pregnant mice onphosphatase CD45, the GTPase p21ras, the kinase MEK,
various days of gestation. The date of finding the vaginal plug wasand the transcription factor Tcf-1 (Molina et al., 1992;
taken as day 0 of gestation.
Levin et al., 1993; Byth et al., 1996; Crompton et al., Mice expressing the transgenic TCR (TCR-aT/bT) reactive with
1996; Van Oers et al., 1996; Verbeek et al., 1995). The male-specific antigen HY and backcrossed onto the C57BL/6 back-
positioning of Rho in the signal transduction pathways ground (H-2b) were kindly provided by Harald von Boehmer (Kisie-
low et al., 1988). Em-bcl-2 mice (strain bcl-2-25), expressing humanregulated by the pre-TCR relative to these other signal-
bcl-2 in the thymus and peripheral T cell compartments, were a giftingmolecules will be the focus of future studies. It should
from Suzanne Cory (Strasser et al., 1991). C3/HY TCR or C3/bcl-2also be emphasized that the positioning of all of these
transgenic mice were generated by intercrossing the respective
signaling molecules in pre-T cells is complicated by the parental strains. Thymi from F1 offspring were obtained from new-
fact that it is not known whether the pre-TCR complex born and 4-week-old mice.
initiates the proliferative expansion of the pre±T cells Litters were typed for inheritance of the transgenes by polymerase
chain reaction (PCR) analysis of genomic DNA.directly or whether it works indirectly via induction or
priming of cytokine pathways. For example, pre-T cells
express IL-7R (Sudo et al., 1993), and no one has yet Reverse Transcriptase PCR from Fetal Thymus
analyzed the cell cycle status of the late pre-T cells in Fetal thymic lobes (days 13±17) from one litter were dissolved in
mice deficient in expression of the IL-7R complex. 500 ml RNazol (Cinna Scientific). Total RNAwas extracted according
to the manufacturer's protocol and subjected to DNase treatment.Recent studies have observed that the extracellular
The reverse transcriptase (RT) reaction was performed using ran-receptors and transcription factors that control fetal and
dom hexamer primers, and the cDNA obtained was used as templateadult thymic development can differ. For example, mice
for PCR reactions employing primer specific for hypoxanthinephos-
lacking expression of the transcription factor Ikaros phoribosyltransferase (59CACAGGACTAGAAC ACCTGC-39 and
show complete blockage of fetal thymic development 59-GCTGGTGAAAAGGACCTCT-39), p56lck (59-GCCCATCCGGAATG
but are able to undergo a postnatal wave of thymic GCTCTG-39 and 59-CGCCACGAAGTTGAAGGG-39), RhoA (59-TGTT
TGAGAACTATGTGGC-39 and 59-CCGAAGATCCTTCTTATTCCCdifferentiation that generatesnearly normal levels of thy-
AAC-39), and C3 transferase (59-GAGGGAACCCAGTCAGTCAGGmocytes in adult mice (Wang et al., 1996). Conversely,
AGC-39 and 59-CTGATTTGCTTAGTCCATAC-39). PCR reactionsmice lacking expression of a4 integrins have a normal
were performed in 20 mM ammonium sulphate, 75 mM Tris-HCl (pH
pattern of fetal thymic development, but after birth the 9.0), 0.01% Tween 20, 1.2 mM MgCl2, 200 mM dNTP, 0.5 U Taq DNA
further production of mature T cells is blocked (Arroyo et polymerase, and 1 mM of each primer. DNA was amplified for 35
al., 1996). In addition, mice deficient in the transcription cycles at an annealing temperature of 578C. PCR products were
separated in 2% agarose gels and stained with ethidium bromide.factor Tcf-1 develop fetal T cells but show a progressive
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Southern Hybridization References
PCR products on agarose gels were transferred to nitrocellulose
Abraham, K.M., Levin, S.D., Marth, J.D., Forbush, K.A., and Perlmut-membranes (Hybond N, Amersham) by Southern blotting in 0.4 M
ter, R.M. (1991). Thymic tumorigenesis induced by overexpressionNaOH for 1±3 hr and hybridized with 32P±end-labeled oligonuc-
of p56lck. Proc. Nat. Acad. Sci. USA 88, 3977±3981.leotides specific for the various PCR products (p56lck: 59-GCC
CATCCGGAATGGCTCTG-39, RhoA: 59-GTGGGACACAGCTGGGC Aktories, K. (1994). Clostridial ADP ribosylating toxins: effect on ATP
AGG-39, and C3 transferase: 59-GCCACCATGGAGCAGAAGCTGAT and GTP binding proteins. Mol. Cell. Biol 138, 167±176.
CTCCG-39). Aktories, K., and Just, I. (1995). In vitro ADP-ribosylation of Rho by
bacterial ADP-ribosyltransferases. Meth. Enzymol. 256, 185±196.
Flow Cytometric Analysis Alberola-Ila, J.,Forbush, K.A., Seger, R., Krebs, E.G., and Perlmutter,
Fetal thymus lobes were obtained from time-mated pregnant mice R.M. (1995). Selective requirement for MAP kinase activation in thy-
of various ages of gestation. Thymocytes were released by gently mocyte differentiation. Nature 373, 620±623.
pressing under a coverslip and were collected and washed in RPMI Alberola-Ila, J., Hogquist, K.A., Swan, K.A., Bevan, M.J., Perlmutter,
1640 media. Before staining the cells were incubated with anti- R. G. (1996). Positive and negative selection invoke distinct signaling
FcgRII blocking monoclonal antibody (MAb) to prevent any nonspe- pathways. J. Exp. Med. 184, 9±18.
cific staining. Flow cytometry was performed by staining freshly
Anderson, S.J., Abraham, K.M., Nakayama, T., Singer, A., and Perl-isolated thymocytes in 100 ml of phosphate-buffered saline supple-
mutter, R.M. (1992). Inhibition of T-cell receptor b-chain gene re-mented with 0.5% bovine serum albumin on ice for 30 min; the
arrangement by overexpression of the non-receptor protein-tyro-
samples were washed twice between the incubations. All of the
sine kinase p56lck. EMBO J. 11, 4877±4886.
antibodies used were conjugated to fluorescein isothiocyanate
Anderson, G., Moore, N.C., Owen, J.J., and Jenkinson, E.J. (1996).(FITC), phycoerythrin (PE), or biotin. Biotinylated antibodies were
Cellular interactions in thymocyte development. Annu. Rev. Immu-revealed with streptavidin-Tricolor (Caltag). For three-color analysis,
nol. 14, 73±99.cells were first stained with biotin-conjugated antibodies, followed
Arroyo, A.G., Yang, J.T., Rayburn, H., and Hynes, R.O. (1996). Differ-by staining with a cocktail of streptavidin-Tricolor (Caltag) and PE-
ential requirements for alpha4 integrins during fetal and adult hema-labeled and FITC-labeled MAbs. The following Pharmigen MAbs
topoiesis. Cell 85, 997±1008.were used: CD8 (53-5.8), CD4 (RM4-5), CD25 (IL2Ra chain, 3C7),
Boise, L.H., Minn, A.J., Noel, P.J., June, C.H., Accavitti, M.A., Lind-abTCR (b chain, H57-597), B220 (CD45R, RA3-6B2), CD44 (Pgp-1,
sten, T., and Thompson, C.B. (1995). CD28 costimulation can pro-IM7), CD2 (LFA-2, RM2-5), c-Kit (CD117, 2B8), Mac1 (a chain, M1/
mote T cell survival by enhancing the expression of Bcl-xL. Immunity70), Gr1 (Ly-6G, RB6-8C5), and g/dTCR (GL3). The rat anti-mouse
3, 87±98.IL-7Ra MAb, revealed with a secondary goat anti-rat FITC-labeled
Byth, K.F., Conroy, L.A., Howlett, S., Smith, A.J.H., May, J., Alexan-immunoglobulin G (Sigma), was a generous gift from T. Sudo (Toray
der, D.R., and Holmes, N. (1996). CD45-null transgenic mice revealIndustries, Kamakura, Japan). Cells were anlyzed on a FACScan
a positive regulatory role for CD45 in early thymocyte development,(Becton Dickinson) using CellQuest software (Becton Dickinson).
in the selection of CD41CD81 thymocytes, and in B cell maturation.Viable cells were gated on the basis of forward- and side-light scat-
J. Exp. Med. 183, 1707±1718.tering.
Cao, X.Q., Shores, E.W., Huli, J., Anver, M.R., Kelsall, B.L., Russell,
S.M., Drago, J., Noguchi, M., Grinberg, A., Bloom, E.T., et al. (1995).Apoptosis Assay
Defective lymphoid development in mice lacking expression of theTotal thymocytes were stained as above with FITC- and PE-labeled
common cytokine receptor-g chain. Immunity 2, 223±238.MAbs. After washing they were incubated with (7-AAD) (Calbiochem,
Chaffin, K.E., Beals, C.R., Wilkie, T.M., Forbush, K.A., Simon, M.I.,San Diego, CA) for 20 min at 48C protected from light. Cells were
and Perlmutter, R.M. (1990). Dissection of thymocyte signaling path-analyzed by flow cytometry, and viable and apoptotic thymocytes
ways by in vivo expression of pertussis toxin ADP-ribosyltransfer-from individually gated populations on the basis of surface marker
ase. EMBO J. 9, 3821±3829.expression were identified by a low or intermediate±high level of
Charlene-Liao, X., and Littman, D. (1995). Altered T cell receptor7-AAD staining, as described (Schmid et al., 1994).
signaling and disrupted T cell development in mice lacking Itk. Im-
munity 3, 757±769.Cell Cycle Analysis
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positive thymocyte. Cell 86, 243±251.min at 378C. After washing the cells were analyzed (7 3 105 per
Crompton, T., Outram, S.V., Buckland, J., and Owen, M.J. (1997). Asample) on a FACS Vantage (Becton Dickinson) using an ultraviolet
transgenic T cell receptor restores thymocyte differentiation in the(351±363 nM) light source measuring blue fluorescence from
interleukin-7 receptor a chain-deficient mice. Eur. J. Immunol. 27,Hoechst 33342 between 390 and 489 nM. Simultaneous analysis of
100±104.cellular DNA content in cells counterstained with PE, FITC, or Tri-
color reagents was by standard techniques. DiSanto, J.P., Muller, W., Guy Grand, D., Fischer, A., and Rajewsky,
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